Access to treatments will continue while the appraisal is ongoing. This will be the case for people starting the treatments as well as those already taking the treatments. Once the appraisal has ended, new patients will only be initiated on treatments that have been recommended in NICE’s final guidance. Existing patients will be unaffected as the flexible commercial mechanism ensures continued access for patients already receiving any of the licensed treatments following the conclusion of a full NICE evaluation.